From Financialisation to Innovation in UK Big Pharma

The tension between innovation and financialisation is central to the business corporation. Innovation entails a ''retain-and-reinvest'' allocation regime that can form a foundation for stable and equitable economic growth. Driven by shareholder-value ideology, financialisation entails a shift to ''downsize-and-distribute''. This Element investigates this tension in global pharmaceuticals, focusi...